iMedConsent Application Achieves ONC-ATCB 2011/2012 EHR Certification from ICSA Labs

Thu Feb 14, 2013 9:00am EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130214:nBw145189a

ATLANTA--(Business Wire)--
Dialog Medical, a subsidiary of Standard Register (NYSE:SR), reported today that
its iMedConsent application has achieved 2011 Edition EHR Modular* Inpatient
ONC-ACB Certification, which designates that the software is capable of
supporting providers with Stage 1 meaningful use measures required to qualify
for funding under the American Recovery and Reinvestment Act (ARRA). The
iMedConsent application was certified on January 31, 2013 under ICSA Labs`
ONC-ACB Electronic Health Record program and is compliant in accordance with the
criteria adopted by the Secretary of Health and Human Services. 

"Securing ONC-ACB Certification demonstrates a commitment to supporting
hospitals` meaningful use initiatives," said Tim Kelly, vice president of
marketing for Dialog Medical. "Certification in five inpatient domain criteria
is essential to the attestation needs of our current and prospective clients." 

"Standard Register Healthcare is committed to advancing the patient engagement
strategies of hospitals and providers," said John King, president of Standard
Register Healthcare. "Receipt of ONC-ACB Certification of the iMedConsent
application punctuates our commitment to supporting patient-centered
communications in hospitals seeking funding for their EHR investment under the
ARRA." 

ICSA Labs, an independent division of Verizon, offers vendor-neutral testing and
certification. Its electronic health record certification and testing program
provides verification that the certified EHR technology supports meaningful use,
as well as helps health care organizations protect sensitive and private patient
information. 

iMedConsent application version 3.833 meets the following certification
criteria:

* 170.302(g) Smoking Status 
* 170.302(m) Patient Specific Education Resources 
* 170.306(b) Record Demographics 
* 170.306(e) Electronic Copy of Discharge Instructions 
* 170.306(h) Advance Directives 
* 170.302(o) Access Control 
* 170.302(p) Emergency Access 
* 170.302(q) Automatic Log-off 
* 170.302(r) Audit Log 
* 170.302(s) Integrity 
* 170.302(t) Authentication 
* 170.302(u) General Encryption 
* 170.302(v) Encryption When Exchanging Electronic Health Information

The additional software relied upon to comply with one or more of the
certification criteria included Microsoft SQL Server 2008. 

The iMedConsent application will be showcased by Standard Register Healthcare
and Dialog Medical at the HIMSS13 Annual Conference and Exhibition in booth
1117. 

About Dialog Medical

Dialog Medical, a Standard Register Healthcare company, is the leading provider
of patient engagement solutions including tools for supporting the informed
consent process as well as the provision of pre- and post-procedure instructions
and patient education materials. The company`s iMedConsent application is
currently used by more than 15,000 physicians and in more than 200 hospitals
nationwide. More information on Dialog Medical and its products is available at
www.dialogmedical.com. For additional information on the 2011 Edition EHR
Modular* Inpatient ONC-ACB Certification of the iMedConsent application version
3.833, visit www.dialogmedical.com/meaningful_use/

About Standard Register

Standard Register (NYSE:SR), celebrating 100 years of innovation, is trusted by
the world`s leading companies to advance their reputations by aligning their
communications with corporate standards and priorities. Providing
market-specific insights and a compelling portfolio of solutions to address the
changing business landscape in commercial, healthcare, financial services and
industrial markets, Standard Register is the recognized leader in the management
and execution of mission-critical communications. More information is available
at www.standardregister.com. 

Standard Register Healthcare is a business unit of Standard Register, serving
more than 3,100 clients from across the healthcare delivery network, including
acute, ambulatory, and long-term care, managed care and the suppliers that
support them. A recognized leader in managing critical information and
communications, Standard Register Healthcare, together with Dialog Medical, a
subsidiary of Standard Register, provides industry-leading technology, solutions
and services to accelerate performance, attract and educate patients, enhance
safety and support patient-centered care. More information is available at
www.standardregister.com/healthcare. 

About ICSA Labs

ICSA Labs, an independent division of Verizon, offers third-party testing and
certification of security and health IT products, as well as network-connected
devices, to measure product compliance, reliability and performance for many of
the world`s top security vendors. ICSA Labs is an ISO/IEC 17025:2005 accredited
and 9001:2008 registered organization. Visit http://www.icsalabs.com and
http://www.icsalabs.com/blogs for more information. 

* This EHR Module is 2011 Edition compliant and has been certified by an ONC-ACB
in accordance with the applicable certification criteria adopted by the
Secretary of Health and Human Services. This certification does not represent an
endorsement by the U.S. Department of Health and Human Services or guarantee the
receipt of incentive payments. iMedConsent Application, Version 3.833 was
certified on January 31, 2013.CHPL Product Number: 130003R00

Media contact:
Standard Register Healthcare
Christine Winters, 937-221-1804
christine.winters@standardregister.com
or
Investor contact:
Standard Register
Carol Merry, 614-383-1624
carol.merry@fahlgren.com
or
ICSA Labs
Carlos Arcila, 908-559-8031
carlos.arcila@verizon.com

Copyright Business Wire 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.